HEALTH CARE:
PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
iTeos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops immuno-oncology therapeutics for treatment of patients. iTeos Therapeutics serves customers in the United States and Belgium.
Market Cap | 1.457 Billion | Shares Outstanding | 35.045 Million | Avg 30-day Volume | 239.414 Thousand | ||
P/E Ratio | Dividend Yield | EPS | |||||
Price/Sales | Debt to Equity | EBITDA | |||||
Price to Book Value | 0.0 | Forward PE | -22.31 | Enterprise Value | |||
Total Cash | Current Debt | Gross Profit | |||||
BETA | 0.0 | 52-week High/Low | 43.69 / 17.5 | Price to Cash FLow (P/CF) | -9999999.0 | ||
Data provided by IEX Cloud |
Q4 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
In top 10: | 4 | 3 | 33.33% | 3 (0.18%) | 2 (0.12%) | 50.0% |
Funds Holding: | 71 | 54 | 31.48% | 26 (1.57%) | 18 (1.12%) | 44.44% |
13F shares: | 26.891 Million | 24.903 Million | 7.98% | 15.844 Million | 15.379 Million | 3.02% |
% Ownership | 76.7324 | 71.0596 | 7.98% | 45.2102 | 43.885 | 3.02% |
New Positions: | 21 | 53 | -60.38% | 8 | 18 | -55.56% |
Increased Positions | 24 | 6 | ||||
Closed Positions | 4 | |||||
Reduced Positions | 12 | 6 | ||||
Total Calls | ||||||
Total Puts | ||||||
PUT/CALL Ratio | ||||||
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
0 | 2020-11-09 | 2 | |
|
72,243 | 2020-07-28 | 1 | |
MPM BIOVENTURES 2014 (B), L.P. MPM ASSET MANAGEMENT INVESTORS BV2014 LLC |
|
9,510,692 | 2020-07-28 | 1 |
|
4,417,259 | 2020-07-28 | 1 | |
|
9,510,692 | 2020-07-28 | 1 | |
MPM ONCOLOGY IMPACT MANAGEMENT GP LLC |
|
15,459,380 | 2020-07-28 | 2 |
|
7,409,518 | 2020-07-28 | 2 | |
|
0 | 2020-07-23 | 1 | |
|
0 | 2020-07-23 | 1 | |
|
0 | 2020-07-23 | 2 | |
|
0 | 2020-07-23 | 1 | |
|
0 | 2020-07-23 | 1 | |
|
0 | 2020-07-23 | 1 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 18:15:03 UTC | -0.2562 | 0.3262 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 17:45:03 UTC | -0.2562 | 0.3262 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 17:15:03 UTC | -0.2562 | 0.3262 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 16:45:03 UTC | -0.2449 | 0.3149 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 16:15:02 UTC | -0.2449 | 0.3149 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 15:45:03 UTC | -0.2449 | 0.3149 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 15:15:02 UTC | -0.2449 | 0.3149 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 14:45:03 UTC | -0.2371 | 0.3071 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 14:15:03 UTC | -0.2371 | 0.3071 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 13:45:03 UTC | -0.2371 | 0.3071 | 30000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 13:15:03 UTC | -0.2371 | 0.3071 | 35000 |
ITEOS THERAPEUTICS INC ITOS | 2021-03-01 12:45:03 UTC | -0.2371 | 0.3071 | 35000 |
ITEOS THERAPEUTICS INC ITOS | 2021-02-26 22:15:02 UTC | -0.2371 | 0.3071 | 40000 |
ITEOS THERAPEUTICS INC ITOS | 2021-02-26 21:45:03 UTC | -0.2371 | 0.3071 | 40000 |
ITEOS THERAPEUTICS INC ITOS | 2021-02-26 21:15:02 UTC | -0.2371 | 0.3071 | 40000 |
ITEOS THERAPEUTICS INC ITOS | 2021-02-26 20:45:03 UTC | -0.2371 | 0.3071 | 40000 |
ITEOS THERAPEUTICS INC ITOS | 2021-02-26 20:15:03 UTC | -0.2371 | 0.3071 | 40000 |
ITEOS THERAPEUTICS INC ITOS | 2021-02-26 19:45:03 UTC | -0.2371 | 0.3071 | 40000 |
ITEOS THERAPEUTICS INC ITOS | 2021-02-26 19:15:03 UTC | -0.2371 | 0.3071 | 40000 |
ITEOS THERAPEUTICS INC ITOS | 2021-02-26 18:45:03 UTC | -0.2371 | 0.3071 | 40000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|